{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:43:42Z","timestamp":1793727822531,"version":"4.6.1"},"reference-count":227,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41574-021-00575-1","type":"journal-article","created":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T06:03:16Z","timestamp":1635228196000},"page":"23-42","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":134,"title":["Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities"],"prefix":"10.1038","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-8986","authenticated-orcid":false,"given":"Sara","family":"SantaCruz-Calvo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Bharath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1573-3787","authenticated-orcid":false,"given":"Gabriella","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"SantaCruz-Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raji Rajesh","family":"Lenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Lutshumba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam D.","family":"Bachstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-5740","authenticated-orcid":false,"given":"Barbara S.","family":"Nikolajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,26]]},"reference":[{"key":"575_CR1","unstructured":"World Health Organization. Obesity and overweight. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight (2021)."},{"key":"575_CR2","unstructured":"World Health Organization. Diabetes. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/diabetes (2021)."},{"key":"575_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jalz.2017.06.2637","volume":"14","author":"A Singh-Manoux","year":"2018","unstructured":"Singh-Manoux, A. et al. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimers Dement. 14, 178\u2013186 (2018).","journal-title":"Alzheimers Dement."},{"key":"575_CR4","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0140-6736(19)31277-2","volume":"394","author":"CE Kearns","year":"2019","unstructured":"Kearns, C. E. & Bero, L. A. Conflicts of interest between the sugary food and beverage industry and dental research organisations: time for reform. Lancet 394, 194\u2013196 (2019).","journal-title":"Lancet"},{"key":"575_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1172\/JCI88876","volume":"127","author":"T Mclaughlin","year":"2017","unstructured":"Mclaughlin, T., Ackerman, S. E., Shen, L. & Engleman, E. Role of innate and adaptive immunity in obesity-associated metabolic disease. J. Clin. Invest. 127, 5\u201313 (2017).","journal-title":"J. Clin. Invest."},{"key":"575_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cmet.2014.05.005","volume":"20","author":"I Wernstedt Asterholm","year":"2014","unstructured":"Wernstedt Asterholm, I. et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 20, 103\u2013118 (2014).","journal-title":"Cell Metab."},{"key":"575_CR7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1681\/ASN.2015030252","volume":"27","author":"P Stenvinkel","year":"2016","unstructured":"Stenvinkel, P. et al. Inflammation modifies the paradoxical association between body mass index and mortality in hemodialysis patients. J. Am. Soc. Nephrol. 27, 1479\u20131486 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"575_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501332","volume":"2","author":"S Nishimoto","year":"2016","unstructured":"Nishimoto, S. et al. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. Sci. Adv. 2, e1501332 (2016).","journal-title":"Sci. Adv."},{"key":"575_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","volume":"271","author":"GS Hotamisligil","year":"1996","unstructured":"Hotamisligil, G. S. et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-\u03b1- and obesity-induced insulin resistance. Science 271, 665\u2013668 (1996).","journal-title":"Science"},{"key":"575_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/387206a0","volume":"387","author":"F Zhang","year":"1997","unstructured":"Zhang, F. et al. Crystal structure of the obese protein leptin-E100. Nature 387, 206\u2013209 (1997).","journal-title":"Nature"},{"key":"575_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","volume":"65","author":"Y Fazel","year":"2016","unstructured":"Fazel, Y., Koenig, A. B., Sayiner, M., Goodman, Z. D. & Younossi, Z. M. Epidemiology and natural history of non-alcoholic fatty liver disease. Metabolism 65, 1017\u20131025 (2016).","journal-title":"Metabolism"},{"key":"575_CR12","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3389\/fimmu.2019.01587","volume":"10","author":"R Liu","year":"2019","unstructured":"Liu, R. & Nikolajczyk, B. S. Tissue immune cells fuel obesity-associated inflammation in adipose tissue and beyond. Front. Immunol. 10, 1587 (2019).","journal-title":"Front. Immunol."},{"key":"575_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/sj.ijo.0803632","volume":"31","author":"M Zeyda","year":"2007","unstructured":"Zeyda, M. et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int. J. Obes. 31, 1420\u20131428 (2007).","journal-title":"Int. J. Obes."},{"key":"575_CR14","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nm.2002","volume":"15","author":"M Feuerer","year":"2009","unstructured":"Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930\u2013939 (2009).","journal-title":"Nat. Med."},{"key":"575_CR15","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1161\/ATVBAHA.116.307166","volume":"36","author":"DB Harmon","year":"2016","unstructured":"Harmon, D. B. et al. Protective role for B-1b B cells and IgM in obesity-associated inflammation, glucose intolerance, and insulin resistance. Arterioscler. Thromb. Vasc. Biol. 36, 682\u2013691 (2016).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"575_CR16","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1073\/pnas.1423486112","volume":"112","author":"D Cipolletta","year":"2015","unstructured":"Cipolletta, D., Cohen, P., Spiegelman, B. M., Benoist, C. & Mathis, D. Appearance and disappearance of the mRNA signature characteristic of Treg cells in visceral adipose tissue: age, diet, and PPAR\u03b3 effects. Proc. Natl Acad. Sci. USA 112, 482\u2013487 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"575_CR17","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.1964","volume":"15","author":"S Nishimura","year":"2009","unstructured":"Nishimura, S. et al. CD8+effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914\u2013920 (2009).","journal-title":"Nat. Med."},{"key":"575_CR18","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nm.2353","volume":"17","author":"DA Winer","year":"2011","unstructured":"Winer, D. A. et al. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17, 610\u2013617 (2011).","journal-title":"Nat. Med."},{"key":"575_CR19","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1161\/ATVBAHA.114.304636","volume":"34","author":"T McLaughlin","year":"2014","unstructured":"McLaughlin, T. et al. T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler. Thromb. Vasc. Biol. 34, 2632\u20132636 (2014).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"575_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1172\/JCI29881","volume":"117","author":"CN Lumeng","year":"2007","unstructured":"Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175\u2013184 (2007). In this study, adipose tissue macrophages undergo a phenotypic switch from an anti-inflammatory M2 polarization state to a proinflammatory M1 polarization state upon high-fat feeding, in the process losing their protective capacity.","journal-title":"J. Clin. Invest."},{"key":"575_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ni.3659","volume":"18","author":"E Dror","year":"2017","unstructured":"Dror, E. et al. Postprandial macrophage-derived IL-1\u03b2 stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nat. Immunol. 18, 283\u2013292 (2017).","journal-title":"Nat. Immunol."},{"key":"575_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cmet.2018.12.003","volume":"29","author":"W Ying","year":"2019","unstructured":"Ying, W. et al. Expansion of islet-resident macrophages leads to inflammation affecting \u03b2 cell proliferation and function in obesity. Cell Metab. 29, 457\u2013474.e5 (2019).","journal-title":"Cell Metab."},{"key":"575_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/oby.20615","volume":"22","author":"LN Fink","year":"2014","unstructured":"Fink, L. N. et al. Pro-inflammatory macrophages increase in skeletal muscle of high fat-fed mice and correlate with metabolic risk markers in humans. Obesity 22, 747\u2013757 (2014).","journal-title":"Obesity"},{"key":"575_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.2337\/db14-1238","volume":"64","author":"H Morinaga","year":"2015","unstructured":"Morinaga, H. et al. Characterization of distinct subpopulations of hepatic macrophages in HFD\/obese mice. Diabetes 64, 1120\u20131130 (2015).","journal-title":"Diabetes"},{"key":"575_CR25","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/nm.2001","volume":"15","author":"S Winer","year":"2009","unstructured":"Winer, S. et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15, 921\u2013929 (2009).","journal-title":"Nat. Med."},{"key":"575_CR26","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1038\/ijo.2015.104","volume":"39","author":"IM Khan","year":"2015","unstructured":"Khan, I. M. et al. Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance. Int. J. Obes. 39, 1607\u20131618 (2015).","journal-title":"Int. J. Obes."},{"key":"575_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4049\/jimmunol.1501175","volume":"196","author":"M Rau","year":"2016","unstructured":"Rau, M. et al. Progression from nonalcoholic fatty liver to nonalcoholic steatohepatitis is marked by a higher frequency of Th17 cells in the liver and an increased Th17\/resting regulatory T cell ratio in peripheral blood and in the liver. J. Immunol. 196, 97\u2013105 (2016).","journal-title":"J. Immunol."},{"key":"575_CR28","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","volume":"30","author":"AL Gomes","year":"2016","unstructured":"Gomes, A. L. et al. Metabolic inflammation-associated IL-17A causes non-alcoholic steatohepatitis and hepatocellular carcinoma. Cancer Cell 30, 161\u2013175 (2016).","journal-title":"Cancer Cell"},{"key":"575_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00281-019-00745-4","volume":"41","author":"M B\u00f6ni-Schnetzler","year":"2019","unstructured":"B\u00f6ni-Schnetzler, M. & Meier, D. T. Islet inflammation in type 2 diabetes. Semin. Immunopathol. 41, 501\u2013513 (2019).","journal-title":"Semin. Immunopathol."},{"key":"575_CR30","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbrc.2009.05.002","volume":"384","author":"C Duffaut","year":"2009","unstructured":"Duffaut, C., Galitzky, J., Lafontan, M. & Bouloumi\u00e9, A. Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem. Biophys. Res. Commun. 384, 482\u2013485 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"575_CR31","doi-asserted-by":"publisher","first-page":"5133","DOI":"10.1073\/pnas.1215840110","volume":"110","author":"J DeFuria","year":"2013","unstructured":"DeFuria, J. et al. B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. Proc. Natl Acad. Sci. USA 110, 5133\u20135138 (2013). This article shows that B cells are critical regulators of inflammation in T2DM due to their direct ability to promote pro-inflammatory T cell function and secrete a pro-inflammatory cytokine profile.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"575_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.2337\/db14-0554","volume":"64","author":"L Shen","year":"2015","unstructured":"Shen, L. et al. B-1a lymphocytes attenuate insulin resistance. Diabetes 64, 593\u2013603 (2015).","journal-title":"Diabetes"},{"key":"575_CR33","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1172\/JCI24798","volume":"115","author":"TI Novobrantseva","year":"2005","unstructured":"Novobrantseva, T. I. et al. Attenuated liver fibrosis in the absence of B cells. J. Clin. Invest. 115, 3072\u20133082 (2005).","journal-title":"J. Clin. Invest."},{"key":"575_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37403-y","volume":"9","author":"Y Nakamura","year":"2019","unstructured":"Nakamura, Y. et al. Depletion of B cell-activating factor attenuates hepatic fat accumulation in a murine model of nonalcoholic fatty liver disease. Sci. Rep. 9, 977 (2019).","journal-title":"Sci. Rep."},{"key":"575_CR35","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2337\/db10-1805","volume":"60","author":"C-S Kim","year":"2011","unstructured":"Kim, C.-S. et al. Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders. Diabetes 60, 3159\u20133168 (2011).","journal-title":"Diabetes"},{"key":"575_CR36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/cvr\/cvx197","volume":"114","author":"S Steven","year":"2018","unstructured":"Steven, S. et al. CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db\/db mice. Cardiovasc. Res. 114, 312\u2013323 (2018).","journal-title":"Cardiovasc. Res."},{"key":"575_CR37","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.2337\/db05-1673","volume":"55","author":"FM Barb\u00e9-Tuana","year":"2006","unstructured":"Barb\u00e9-Tuana, F. M. et al. CD40-CD40 ligand interaction activates proinflammatory pathways in pancreatic islets. Diabetes 55, 2437\u20132445 (2006).","journal-title":"Diabetes"},{"key":"575_CR38","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/hep.21274","volume":"44","author":"V Schmitz","year":"2006","unstructured":"Schmitz, V. et al. Induction of murine liver damage by overexpression of CD40 ligand provides an experimental model to study fulminant hepatic failure. Hepatology 44, 430\u2013439 (2006).","journal-title":"Hepatology"},{"key":"575_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/oby.21243","volume":"24","author":"B Ip","year":"2016","unstructured":"Ip, B. et al. Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNF\u03b1 production. Obesity 24, 102\u2013112 (2016).","journal-title":"Obesity"},{"key":"575_CR40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.04.010","volume":"145","author":"E Fabbrini","year":"2013","unstructured":"Fabbrini, E. et al. Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. Gastroenterology 145, e3 (2013).","journal-title":"Gastroenterology"},{"key":"575_CR41","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.2337\/db13-1511","volume":"63","author":"E Dalmas","year":"2014","unstructured":"Dalmas, E. et al. T cell-derived IL-22 amplifies IL-1\u03b2-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes. Diabetes 63, 1966\u20131977 (2014).","journal-title":"Diabetes"},{"key":"575_CR42","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-0043-113454","volume":"126","author":"N Yuan","year":"2018","unstructured":"Yuan, N., Zhang, H. F., Wei, Q., Wang, P. & Guo, W. Y. Expression of CD4+CD25+Foxp3+regulatory T cells, interleukin 10 and transforming growth factor \u03b2 in newly diagnosed type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 126, 96\u2013101 (2018).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"575_CR43","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.4049\/jimmunol.1002615","volume":"186","author":"M Jagannathan-Bogdan","year":"2011","unstructured":"Jagannathan-Bogdan, M. et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol. 186, 1162\u20131172 (2011).","journal-title":"J. Immunol."},{"key":"575_CR44","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.humimm.2015.09.007","volume":"76","author":"N Cortez-Espinosa","year":"2015","unstructured":"Cortez-Espinosa, N. et al. CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes. Hum. Immunol. 76, 622\u2013630 (2015).","journal-title":"Hum. Immunol."},{"key":"575_CR45","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.molimm.2018.03.008","volume":"97","author":"J Zhou","year":"2018","unstructured":"Zhou, J. et al. Non-obese type 2 diabetes patients present intestinal B cell dysregulations associated with hyperactive intestinal Tfh cells. Mol. Immunol. 97, 27\u201332 (2018).","journal-title":"Mol. Immunol."},{"key":"575_CR46","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/1440-1681.12740","volume":"44","author":"J Zhan","year":"2017","unstructured":"Zhan, J. et al. Reduced inflammatory responses of follicular helper T cell promote the development of regulatory B cells after Roux-en-Y gastric bypass. Clin. Exp. Pharmacol. Physiol. 44, 556\u2013565 (2017).","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"575_CR47","first-page":"186","volume":"23","author":"S Chashmniam","year":"2020","unstructured":"Chashmniam, S., Madani, N. H., Ghoochani, B. B. F. N. M., Safari-Alighiarloo, N. & Khamseh, M. E. The metabolome profiling of obese and non-obese individuals: metabolically healthy obese and unhealthy non-obese paradox. Iran. J. Basic. Med. Sci. 23, 186\u2013194 (2020).","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"575_CR48","doi-asserted-by":"publisher","DOI":"10.20900\/immunometab20200011","volume":"2","author":"S SantaCruz-Calvo","year":"2020","unstructured":"SantaCruz-Calvo, S. et al. Commentary on Camell et al., aging induces Nlrp3 inflammasome-dependent adipose B cell expansion to impair metabolic homeostasis. Immunometabolism 2, e200011 (2020).","journal-title":"Immunometabolism"},{"key":"575_CR49","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1159\/000443073","volume":"38","author":"X Zhai","year":"2016","unstructured":"Zhai, X. et al. Elevated B cell activation is associated with type 2 diabetes development in obese subjects. Cell. Physiol. Biochem. 38, 1257\u20131266 (2016).","journal-title":"Cell. Physiol. Biochem."},{"key":"575_CR50","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00125-010-1730-z","volume":"53","author":"M Jagannathan","year":"2010","unstructured":"Jagannathan, M. et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 53, 1461\u20131471 (2010).","journal-title":"Diabetologia"},{"key":"575_CR51","doi-asserted-by":"publisher","first-page":"5052812","DOI":"10.1155\/2017\/5052812","volume":"2017","author":"C Deng","year":"2017","unstructured":"Deng, C. et al. The imbalance of B-lymphocyte subsets in subjects with different glucose tolerance: relationship with metabolic parameter and disease status. J. Diabetes Res. 2017, 5052812 (2017).","journal-title":"J. Diabetes Res."},{"key":"575_CR52","unstructured":"Center for Disease Control. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. https:\/\/www.cdc.gov\/nchs\/products\/databriefs\/db360.htm (2020)."},{"key":"575_CR53","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/sj.ijo.0802006","volume":"26","author":"AS Jackson","year":"2002","unstructured":"Jackson, A. S. et al. The effect of sex, age and race on estimating percentage body fat from body mass index: the Heritage Family Study. Int. J. Obes. 26, 789\u2013796 (2002).","journal-title":"Int. J. Obes."},{"key":"575_CR54","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1172\/JCI118285","volume":"96","author":"MD Jensen","year":"1995","unstructured":"Jensen, M. D. Gender differences in regional fatty acid metabolism before and after meal ingestion. J. Clin. Invest. 96, 2297\u20132303 (1995).","journal-title":"J. Clin. Invest."},{"key":"575_CR55","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","volume":"17","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia, T. et al. Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab. 17, 644\u2013656 (2013).","journal-title":"Cell Metab."},{"key":"575_CR56","first-page":"579","volume":"82","author":"MF Saad","year":"1997","unstructured":"Saad, M. F. et al. Sexual dimorphism in plasma leptin concentration. J. Clin. Endocrinol. Metab. 82, 579\u2013584 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"575_CR57","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00125-019-05040-3","volume":"63","author":"B Tramunt","year":"2020","unstructured":"Tramunt, B. et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 63, 453\u2013461 (2020).","journal-title":"Diabetologia"},{"key":"575_CR58","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1210\/jc.2016-1915","volume":"101","author":"A Nordstr\u00f6m","year":"2016","unstructured":"Nordstr\u00f6m, A., Hadr\u00e9vi, J., Olsson, T., Franks, P. W. & Nordstr\u00f6m, P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J. Clin. Endocrinol. Metab. 101, 3740\u20133746 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"575_CR59","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","volume":"47","author":"KL Margolis","year":"2004","unstructured":"Margolis, K. L. et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women\u2019s Health Initiative Hormone Trial. Diabetologia 47, 1175\u20131187 (2004).","journal-title":"Diabetologia"},{"key":"575_CR60","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3889\/oamjms.2016.024","volume":"4","author":"I Bitoska","year":"2016","unstructured":"Bitoska, I. et al. Effects of hormone replacement therapy on insulin resistance in postmenopausal diabetic women. Open Access Maced. J. Med. Sci. 4, 83\u201388 (2016).","journal-title":"Open Access Maced. J. Med. Sci."},{"key":"575_CR61","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.4049\/jimmunol.1400806","volume":"194","author":"R-Y Chen","year":"2015","unstructured":"Chen, R.-Y. et al. Estradiol inhibits Th17 cell differentiation through inhibition of ROR\u03b3T transcription by recruiting the ER\u03b1\/REA complex to estrogen response elements of the ROR\u03b3T promoter. J. Immunol. 194, 4019\u20134028 (2015).","journal-title":"J. Immunol."},{"key":"575_CR62","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein, S. L. & Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 16, 626\u2013638 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"575_CR63","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41586-020-2040-3","volume":"579","author":"A Vasanthakumar","year":"2020","unstructured":"Vasanthakumar, A. et al. Sex-specific adipose tissue imprinting of regulatory T cells. Nature 579, 581\u2013585 (2020). This paper provides evidence that sex-specific differences in Treg cells from VAT are determined by the tissue niche in a sex-hormone-dependent manner to limit adipose tissue inflammation.","journal-title":"Nature"},{"key":"575_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046057","volume":"7","author":"US Pettersson","year":"2012","unstructured":"Pettersson, U. S., Wald\u00e9n, T. B., Carlsson, P. O., Jansson, L. & Phillipson, M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS ONE 7, e46057 (2012).","journal-title":"PLoS ONE"},{"key":"575_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230885","volume":"15","author":"A Ishikawa","year":"2020","unstructured":"Ishikawa, A. et al. Estrogen regulates sex-specific localization of regulatory T cells in adipose tissue of obese female mice. PLoS ONE 15, e0230885 (2020).","journal-title":"PLoS ONE"},{"key":"575_CR66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2007.01.011","volume":"26","author":"V De Rosa","year":"2007","unstructured":"De Rosa, V. et al. A key role of leptin in the control of regulatory T cell proliferation. Immunity 26, 241\u2013255 (2007).","journal-title":"Immunity"},{"key":"575_CR67","doi-asserted-by":"publisher","first-page":"168","DOI":"10.5625\/lar.2013.29.3.168","volume":"29","author":"W Fungfuang","year":"2013","unstructured":"Fungfuang, W., Terada, M., Komatsu, N., Moon, C. & Saito, T. R. Effects of estrogen on food intake, serum leptin levels and leptin mRNA expression in adipose tissue of female rats. Lab. Anim. Res. 29, 168\u2013173 (2013).","journal-title":"Lab. Anim. Res."},{"key":"575_CR68","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1172\/JCI108646","volume":"59","author":"JH Helderman","year":"1977","unstructured":"Helderman, J. H. & Strom, T. B. Emergence of insulin receptors upon alloimmune T cells in the rat. J. Clin. Invest. 59, 338\u2013344 (1977).","journal-title":"J. Clin. Invest."},{"key":"575_CR69","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/274062a0","volume":"274","author":"JH Helderman","year":"1978","unstructured":"Helderman, J. H. & Strom, T. B. Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature 274, 62\u201363 (1978).","journal-title":"Nature"},{"key":"575_CR70","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1210\/en.2006-0686","volume":"148","author":"A Viardot","year":"2007","unstructured":"Viardot, A., Grey, S. T., Mackay, F. & Chisholm, D. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148, 346\u2013353 (2007).","journal-title":"Endocrinology"},{"key":"575_CR71","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1172\/JCI112848","volume":"79","author":"JH Helderman","year":"1987","unstructured":"Helderman, J. H., Ayuso, R., Rosenstock, J. & Raskin, P. Monocyte-T lymphocyte interaction for regulation of insulin receptors on the activated T lymphocyte. J. Clin. Invest. 79, 566\u2013571 (1987). This research demonstrated that insulin receptor in monocytes perceives the concentration of insulin and transmits this information to T lymphocytes by regulating the number of activation-induced insulin receptors.","journal-title":"J. Clin. Invest."},{"key":"575_CR72","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.bbrc.2005.07.109","volume":"335","author":"FB Stentz","year":"2005","unstructured":"Stentz, F. B. & Kitabchi, A. E. Hyperglycemia-induced activation of human T-lymphocytes with de novo emergence of insulin receptors and generation of reactive oxygen species. Biochem. Biophys. Res. Commun. 335, 491\u2013495 (2005).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"575_CR73","first-page":"551","volume":"29","author":"JH Helderman","year":"1980","unstructured":"Helderman, J. H. & Raskin, P. The T lymphocyte insulin receptor in diabetes and obesity. Intrinsic Binding Defect. Diabetes 29, 551\u2013557 (1980).","journal-title":". Intrinsic Binding Defect. Diabetes"},{"key":"575_CR74","first-page":"216","volume":"5","author":"FB Stentz","year":"2007","unstructured":"Stentz, F. B. & Kitabchi, A. E. Transcriptome and proteome expressions involved in insulin resistance in muscle and activated T-lymphocytes of patients with type 2 diabetes. genomics. Proteom. Bioinforma. 5, 216\u2013235 (2007).","journal-title":"Proteom. Bioinforma."},{"key":"575_CR75","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmet.2018.08.003","volume":"28","author":"S Tsai","year":"2018","unstructured":"Tsai, S. et al. Insulin receptor-mediated stimulation boosts T cell immunity during inflammation and infection. Cell Metab. 28, 922\u2013934.e4 (2018). This study shows that insulin receptor signalling has an important role in the immune response and has an effect on T cell glucose metabolism and amino acid handling.","journal-title":"Cell Metab."},{"key":"575_CR76","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.4049\/jimmunol.1601011","volume":"198","author":"HJ Fischer","year":"2017","unstructured":"Fischer, H. J. et al. The insulin receptor plays a critical role in T cell function and adaptive immunity. J. Immunol. 198, 1910\u20131920 (2017).","journal-title":"J. Immunol."},{"key":"575_CR77","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.4049\/jimmunol.1401225","volume":"194","author":"KC Fairfax","year":"2015","unstructured":"Fairfax, K. C. et al. IL-4\u2013secreting secondary T follicular helper (Tfh) cells arise from memory T cells, not persisting Tfh cells, through a B cell-dependent mechanism. J. Immunol. 194, 2999\u20133010 (2015).","journal-title":"J. Immunol."},{"key":"575_CR78","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.immuni.2011.12.014","volume":"36","author":"P Vijayanand","year":"2012","unstructured":"Vijayanand, P. et al. Interleukin-4 production by follicular helper T cells requires the conserved Il4 enhancer hypersensitivity site V. Immunity 36, 175\u2013187 (2012).","journal-title":"Immunity"},{"key":"575_CR79","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4049\/jimmunol.1302181","volume":"192","author":"JM Han","year":"2014","unstructured":"Han, J. M., Patterson, S. J., Speck, M., Ehses, J. A. & Levings, M. K. Insulin inhibits IL-10-mediated regulatory T cell function: implications for obesity. J. Immunol. 192, 623\u2013629 (2014).","journal-title":"J. Immunol."},{"key":"575_CR80","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191542","volume":"217","author":"D Wu","year":"2020","unstructured":"Wu, D. et al. T reg\u2013specific insulin receptor deletion prevents diet-induced and age-associated metabolic syndrome. J. Exp. Med. 217, e20191542 (2020).","journal-title":"J. Exp. Med."},{"key":"575_CR81","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","volume":"282","author":"SB Heymsfield","year":"1999","unstructured":"Heymsfield, S. B. et al. Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. J. Am. Med. Assoc. 282, 1568\u20131575 (1999).","journal-title":"J. Am. Med. Assoc."},{"key":"575_CR82","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.4049\/jimmunol.177.5.2899","volume":"177","author":"G Palmer","year":"2006","unstructured":"Palmer, G. et al. Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db\/db mice. J. Immunol. 177, 2899\u20132907 (2006).","journal-title":"J. Immunol."},{"key":"575_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1210\/en.2013-1607","volume":"155","author":"LH Dib","year":"2014","unstructured":"Dib, L. H., Ortega, M. T., Fleming, S. D., Chapes, S. K. & Melgarejo, T. Bone marrow leptin signaling mediates obesity-associated adipose tissue inflammation in male mice. Endocrinology 155, 40\u201346 (2014).","journal-title":"Endocrinology"},{"key":"575_CR84","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/29795","volume":"394","author":"GM Lord","year":"1998","unstructured":"Lord, G. M. et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897\u2013901 (1998).","journal-title":"Nature"},{"key":"575_CR85","doi-asserted-by":"publisher","first-page":"136","DOI":"10.4049\/jimmunol.1301158","volume":"192","author":"DC Saucillo","year":"2014","unstructured":"Saucillo, D. C., Gerriets, V. A., Sheng, J., Rathmell, J. C. & MacIver, N. J. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J. Immunol. 192, 136\u2013144 (2014).","journal-title":"J. Immunol."},{"key":"575_CR86","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.4049\/jimmunol.1402996","volume":"194","author":"BS Reis","year":"2015","unstructured":"Reis, B. S. et al. Leptin receptor signaling in T cells is required for Th17 differentiation. J. Immunol. 194, 5253\u20135260 (2015). This paper proposes that leptin receptor has major implications for the understanding of direct regulation of immune effector function under leptin-modulating conditions.","journal-title":"J. Immunol."},{"key":"575_CR87","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/oby.20087","volume":"21","author":"NM Wagner","year":"2013","unstructured":"Wagner, N. M. et al. Circulating regulatory T cells are reduced in obesity and may identify subjects at increased metabolic and cardiovascular risk. Obesity 21, 461\u2013468 (2013).","journal-title":"Obesity"},{"key":"575_CR88","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1742-4933-10-3","volume":"10","author":"S Gupta","year":"2013","unstructured":"Gupta, S., Agrawal, S. & Gollapudi, S. Increased activation and cytokine secretion in B cells stimulated with leptin in aged humans. Immun. Ageing 10, 3 (2013).","journal-title":"Immun. Ageing"},{"key":"575_CR89","doi-asserted-by":"publisher","first-page":"103994","DOI":"10.1016\/j.cellimm.2019.103994","volume":"348","author":"D Frasca","year":"2020","unstructured":"Frasca, D., Diaz, A., Romero, M. & Blomberg, B. B. Leptin induces immunosenescence in human B cells. Cell. Immunol. 348, 103994 (2020).","journal-title":"Cell. Immunol."},{"key":"575_CR90","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.3389\/fimmu.2018.02741","volume":"9","author":"R Maurya","year":"2018","unstructured":"Maurya, R., Bhattacharya, P., Dey, R. & Nakhasi, H. L. Leptin functions in infectious diseases. Front. Immunol. 9, 2741 (2018).","journal-title":"Front. Immunol."},{"key":"575_CR91","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2016.01.028","volume":"44","author":"C Procaccini","year":"2016","unstructured":"Procaccini, C. et al. The proteomic landscape of human ex vivo regulatory and conventional T cells reveals specific metabolic requirements. Immunity 44, 406\u2013421 (2016).","journal-title":"Immunity"},{"key":"575_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217761","volume":"14","author":"N Tanimine","year":"2019","unstructured":"Tanimine, N. et al. Differential effects of 2-deoxy-D-glucose on in vitro expanded human regulatory T cell subsets. PLoS ONE 14, e0217761 (2019).","journal-title":"PLoS ONE"},{"key":"575_CR93","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1016\/j.celrep.2020.01.022","volume":"30","author":"B Shin","year":"2020","unstructured":"Shin, B. et al. Mitochondrial oxidative phosphorylation regulates the fate decision between pathogenic Th17 and regulatory T cells. Cell Rep. 30, 1898\u20131909.e4 (2020).","journal-title":"Cell Rep."},{"key":"575_CR94","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327\u20131333 (2014). This study provides evidence that de novo fatty acid synthesis should be exploited as a new strategy for metabolic immune modulation of TH17 cell-mediated inflammatory disease.","journal-title":"Nat. Med."},{"key":"575_CR95","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.celrep.2015.07.014","volume":"12","author":"Y Endo","year":"2015","unstructured":"Endo, Y. et al. Obesity drives Th17 cell differentiation by inducing the lipid metabolic kinase, ACC1. Cell Rep. 12, 1042\u20131055 (2015).","journal-title":"Cell Rep."},{"key":"575_CR96","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1432-1033.1990.tb15593.x","volume":"190","author":"A Katsurada","year":"1990","unstructured":"Katsurada, A. et al. Effects of nutrients and hormones on transcriptional and post-transcriptional regulation of acetyl-CoA carboxylase in rat liver. Eur. J. Biochem. 190, 435\u2013441 (1990).","journal-title":"Eur. J. Biochem."},{"key":"575_CR97","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1507\/endocrj.K09E-298","volume":"57","author":"LF Zhao","year":"2010","unstructured":"Zhao, L. F. et al. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocr. J. 57, 317\u2013324 (2010).","journal-title":"Endocr. J."},{"key":"575_CR98","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cmet.2019.07.004","volume":"30","author":"DA Nicholas","year":"2019","unstructured":"Nicholas, D. A. et al. Fatty acid metabolites combine with reduced \u03b2 oxidation to activate Th17 inflammation in human type 2 diabetes. Cell Metab. 30, 447\u2013461.e5 (2019). This article shows that mitochondrial alterations combine with increases in fatty acid metabolites to drive chronic T2DM-like inflammation in human peripheral mononuclear cells.","journal-title":"Cell Metab."},{"key":"575_CR99","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2014.06.005","volume":"41","author":"D O\u2019Sullivan","year":"2014","unstructured":"O\u2019Sullivan, D. et al. Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity 41, 75\u201388 (2014).","journal-title":"Immunity"},{"key":"575_CR100","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.cmet.2019.10.013","volume":"31","author":"C Zhang","year":"2020","unstructured":"Zhang, C. et al. STAT3 activation-induced fatty acid oxidation in CD8+ T effector cells is critical for obesity-promoted breast tumor growth. Cell Metab. 31, 148\u2013161.e5 (2020).","journal-title":"Cell Metab."},{"key":"575_CR101","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.cell.2020.11.039","volume":"183","author":"JH Goodman","year":"2020","unstructured":"Goodman, J. H. & Ferrante, A. W. Fighting for fat: gluttonous tumors and starved T cells. Cell 183, 1739\u20131741 (2020).","journal-title":"Cell"},{"key":"575_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219545","volume":"14","author":"D Frasca","year":"2019","unstructured":"Frasca, D., Diaz, A., Romero, M., Thaller, S. & Blomberg, B. B. Metabolic requirements of human pro-inflammatory B cells in aging and obesity. PLoS ONE 14, e0219545 (2019).","journal-title":"PLoS ONE"},{"key":"575_CR103","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","volume":"15","author":"A Rao","year":"1997","unstructured":"Rao, A., Luo, C. & Hogan, P. G. Transcription factors of the Nfat family: regulation and function. Annu. Rev. Immunol. 15, 707\u2013747 (1997).","journal-title":"Annu. Rev. Immunol."},{"key":"575_CR104","first-page":"4972","volume":"185","author":"JP Shaw","year":"2010","unstructured":"Shaw, J. P. et al. Identification of a putative regulator of early T cell activation genes. J. Immunol. 185, 4972\u20134975 (2010).","journal-title":"J. Immunol."},{"key":"575_CR105","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cmet.2019.01.019","volume":"29","author":"U Kaufmann","year":"2019","unstructured":"Kaufmann, U. et al. Calcium signaling controls pathogenic Th17 cell-mediated inflammation by regulating mitochondrial function. Cell Metab. 29, 1104\u20131118.e6 (2019). This paper provides evidence that calcium influx is a critical regulator of mitochondrial function and oxidative stress in pathogenic TH17-mediated multiorgan inflammation.","journal-title":"Cell Metab."},{"key":"575_CR106","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08959-8","volume":"10","author":"M Vaeth","year":"2019","unstructured":"Vaeth, M. et al. Tissue resident and follicular Treg cell differentiation is regulated by CRAC channels. Nat. Commun. 10, 1183 (2019).","journal-title":"Nat. Commun."},{"key":"575_CR107","doi-asserted-by":"publisher","first-page":"107474","DOI":"10.1016\/j.celrep.2020.03.038","volume":"31","author":"CT Berry","year":"2020","unstructured":"Berry, C. T. et al. BCR-induced Ca2+ signals dynamically tune survival, metabolic reprogramming, and proliferation of naive B cells. Cell Rep. 31, 107474 (2020).","journal-title":"Cell Rep."},{"key":"575_CR108","doi-asserted-by":"publisher","first-page":"14418","DOI":"10.1073\/pnas.0703126104","volume":"104","author":"A Quintana","year":"2007","unstructured":"Quintana, A. et al. T cell activation requires mitochondrial translocation to the immunological synapse. Proc. Natl Acad. Sci. USA 104, 14418\u201314423 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"575_CR109","doi-asserted-by":"publisher","first-page":"27494","DOI":"10.1016\/S0021-9258(18)47012-3","volume":"269","author":"AE Rusi\u00f1ol","year":"1994","unstructured":"Rusi\u00f1ol, A. E., Cui, Z., Chen, M. H. & Vance, J. E. A unique mitochondria-associated membrane fraction from rat liver has a high capacity for lipid synthesis and contains pre-Golgi secretory proteins including nascent lipoproteins. J. Biol. Chem. 269, 27494\u201327502 (1994).","journal-title":"J. Biol. Chem."},{"key":"575_CR110","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1083\/jcb.200608073","volume":"175","author":"G Szabadkai","year":"2006","unstructured":"Szabadkai, G. et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels. J. Cell Biol. 175, 901\u2013911 (2006).","journal-title":"J. Cell Biol."},{"key":"575_CR111","doi-asserted-by":"publisher","first-page":"570","DOI":"10.4049\/jimmunol.1700109","volume":"199","author":"H Tang","year":"2017","unstructured":"Tang, H. et al. Loss of IP3 receptor\u2013mediated Ca2+ release in mouse B cells results in abnormal B cell development and function. J. Immunol. 199, 570\u2013580 (2017).","journal-title":"J. Immunol."},{"key":"575_CR112","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.immuni.2018.02.012","volume":"48","author":"GR Bantug","year":"2018","unstructured":"Bantug, G. R. et al. Mitochondria-endoplasmic reticulum contact sites function as immunometabolic hubs that orchestrate the rapid recall response of memory CD8+ T cells. Immunity 48, 542\u2013555.e6 (2018).","journal-title":"Immunity"},{"key":"575_CR113","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/nm.3735","volume":"20","author":"AP Arruda","year":"2014","unstructured":"Arruda, A. P. et al. Chronic enrichment of hepatic endoplasmic reticulum-mitochondria contact leads to mitochondrial dysfunction in obesity. Nat. Med. 20, 1427\u20131435 (2014).","journal-title":"Nat. Med."},{"key":"575_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006661","volume":"15","author":"JM Han","year":"2019","unstructured":"Han, J. M. & Periwal, V. A mathematical model of calcium dynamics: obesity and mitochondria-associated ER membranes. PLoS Comput. Biol. 15, e1006661 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"575_CR115","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2337\/db17-0316","volume":"67","author":"E Tubbs","year":"2018","unstructured":"Tubbs, E. et al. Disruption of mitochondria-associated endoplasmic reticulum membrane (MAM) integrity contributes to muscle insulin resistance in mice and humans. Diabetes 67, 636\u2013650 (2018).","journal-title":"Diabetes"},{"key":"575_CR116","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.2337\/db13-1751","volume":"63","author":"E Tubbs","year":"2014","unstructured":"Tubbs, E. et al. Mitochondria-associated endoplasmic reticulum membrane (MAM) integrity is required for insulin signaling and is implicated in hepatic insulin resistance. Diabetes 63, 3279\u20133294 (2014).","journal-title":"Diabetes"},{"key":"575_CR117","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3788","volume":"1","author":"H Riaz","year":"2018","unstructured":"Riaz, H. et al. Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies. JAMA Netw. Open 1, e183788 (2018).","journal-title":"JAMA Netw. Open"},{"key":"575_CR118","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1161\/CIRCRESAHA.118.313563","volume":"124","author":"JM Tublin","year":"2019","unstructured":"Tublin, J. M., Adelstein, J. M., Monte, F., del, Combs, C. K. & Wold, L. E. Getting to the heart of Alzheimer disease. Circ. Res. 124, 142\u2013149 (2019).","journal-title":"Circ. Res."},{"key":"575_CR119","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels, G. J. & Despa, F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat. Rev. Endocrinol. 14, 591\u2013604 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"575_CR120","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1212\/WNL.45.6.1161","volume":"45","author":"T Yoshitake","year":"1995","unstructured":"Yoshitake, T. et al. Incidence and risk factors of vascular dementia and Alzheimer\u2019s disease in a defined elderly Japanese population: the Hisayama Study. Neurology 45, 1161\u20131168 (1995).","journal-title":"Neurology"},{"key":"575_CR121","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","volume":"53","author":"A Ott","year":"1999","unstructured":"Ott, A. et al. Diabetes mellitus and the risk of dementia: the Rotterdam Study. Neurology 53, 1937\u20131942 (1999).","journal-title":"Neurology"},{"key":"575_CR122","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/ageing\/afl123","volume":"36","author":"EC Gorospe","year":"2007","unstructured":"Gorospe, E. C. & Dave, J. K. The risk of dementia with increased body mass index. Age Ageing 36, 23\u201329 (2007).","journal-title":"Age Ageing"},{"key":"575_CR123","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1093\/ije\/dyaa099","volume":"49","author":"Y Ma","year":"2020","unstructured":"Ma, Y., Ajnakina, O., Steptoe, A. & Cadar, D. Higher risk of dementia in English older individuals who are overweight or obese. Int. J. Epidemiol. 49, 1353\u20131365 (2020).","journal-title":"Int. J. Epidemiol."},{"key":"575_CR124","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","volume":"3","author":"N Qizilbash","year":"2015","unstructured":"Qizilbash, N. et al. BMI and risk of dementia in two million people over two decades: a retrospective cohort study. Lancet Diabetes Endocrinol. 3, 431\u2013436 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"575_CR125","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1001\/archneur.65.9.1211","volume":"65","author":"V Haroutunian","year":"2008","unstructured":"Haroutunian, V. et al. Role of the neuropathology of Alzheimer disease in dementia in the oldest-old. Arch. Neurol. 65, 1211\u20131217 (2008).","journal-title":"Arch. Neurol."},{"key":"575_CR126","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.18632\/aging.102738","volume":"12","author":"Z Sun","year":"2020","unstructured":"Sun, Z. et al. Late-life obesity is a protective factor for prodromal Alzheimer\u2019s disease: a longitudinal study. Aging 12, 2005\u20132017 (2020).","journal-title":"Aging"},{"key":"575_CR127","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/nature16151","volume":"528","author":"SP Bapat","year":"2015","unstructured":"Bapat, S. P. et al. Depletion of fat-resident Treg cells prevents age-associated insulin resistance. Nature 528, 137\u2013141 (2015).","journal-title":"Nature"},{"key":"575_CR128","first-page":"386","volume":"20","author":"PK Crane","year":"2013","unstructured":"Crane, P. K. et al. Glucose levels and risk of dementia. Forsch. Komplementarmed. 20, 386\u2013387 (2013).","journal-title":"Forsch. Komplementarmed."},{"key":"575_CR129","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s007020050068","volume":"105","author":"L Fr\u00f6lich","year":"1998","unstructured":"Fr\u00f6lich, L. et al. Brain insulin and insulin receptors in aging and sporadic Alzheimer\u2019s disease. J. Neural Transm. 105, 423\u2013438 (1998).","journal-title":"J. Neural Transm."},{"key":"575_CR130","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI57256","volume":"122","author":"TR Bomfim","year":"2012","unstructured":"Bomfim, T. R. et al. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated A\u03b2 oligomers. J. Clin. Invest. 122, 1339\u20131353 (2012). In a mouse model of Alzheimer disease, the anti-T2DM drug exendin-4 decreased levels of hippocampal IRS-1pSer and activated JNK and improved behavioural measures of cognition.","journal-title":"J. Clin. Invest."},{"key":"575_CR131","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1172\/JCI59903","volume":"122","author":"K Talbot","year":"2012","unstructured":"Talbot, K. et al. Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J. Clin. Invest. 122, 1316\u20131338 (2012).","journal-title":"J. Clin. Invest."},{"key":"575_CR132","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1001\/archinte.165.14.1651","volume":"165","author":"O Okereke","year":"2005","unstructured":"Okereke, O., Hankinson, S. E., Hu, F. B. & Grodstein, F. Plasma C peptide level and cognitive function among older women without diabetes mellitus. Arch. Intern. Med. 165, 1651\u20131656 (2005).","journal-title":"Arch. Intern. Med."},{"key":"575_CR133","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/01.JGP.0000240983.25359.00","volume":"14","author":"O Okereke","year":"2006","unstructured":"Okereke, O. et al. Plasma C-peptide and cognitive performance in older men without diabetes. Am. J. Geriatr. Psychiatry 14, 1041\u20131050 (2006).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"575_CR134","doi-asserted-by":"publisher","first-page":"104608","DOI":"10.1016\/j.nbd.2019.104608","volume":"134","author":"E van Duinkerken","year":"2020","unstructured":"van Duinkerken, E. & Ryan, C. M. Diabetes mellitus in the young and the old: effects on cognitive functioning across the life span. Neurobiol. Dis. 134, 104608 (2020).","journal-title":"Neurobiol. Dis."},{"key":"575_CR135","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fendo.2014.00161","volume":"5","author":"E Bl\u00e1zquez","year":"2014","unstructured":"Bl\u00e1zquez, E., Vel\u00e1zquez, E., Hurtado-Carneiro, V. & Ruiz-Albusac, J. M. Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer\u2019s disease. Front. Endocrinol. 5, 161 (2014).","journal-title":"Front. Endocrinol."},{"key":"575_CR136","doi-asserted-by":"publisher","first-page":"e756","DOI":"10.1097\/MJT.0000000000000926","volume":"26","author":"J Lu","year":"2018","unstructured":"Lu, J. & Xu, Z. Efficacy of intranasal insulin in improving cognition in mild cognitive impairment and Alzheimer disease: a systematic review and meta-analysis. Am. J. Ther. 26, e756\u2013e762 (2018).","journal-title":"Am. J. Ther."},{"key":"575_CR137","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","volume":"60","author":"GS Watson","year":"2003","unstructured":"Watson, G. S. et al. Insulin increases CSF A\u03b242 levels in normal older adults. Neurology 60, 1899\u20131903 (2003).","journal-title":"Neurology"},{"key":"575_CR138","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1471-4159.2012.07668.x","volume":"121","author":"N Yamamoto","year":"2012","unstructured":"Yamamoto, N. et al. Brain insulin resistance accelerates A\u03b2 fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes. J. Neurochem. 121, 619\u2013628 (2012).","journal-title":"J. Neurochem."},{"key":"575_CR139","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/path.5056","volume":"245","author":"AF Batista","year":"2018","unstructured":"Batista, A. F. et al. The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease. J. Pathol. 245, 85\u2013100 (2018).","journal-title":"J. Pathol."},{"key":"575_CR140","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13024-017-0222-8","volume":"12","author":"A Sommer","year":"2017","unstructured":"Sommer, A., Winner, B. & Prots, I. The Trojan horse \u2013 neuroinflammatory impact of T cells in neurodegenerative diseases. Mol. Neurodegener. 12, 78 (2017).","journal-title":"Mol. Neurodegener."},{"key":"575_CR141","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.bbi.2010.12.004","volume":"25","author":"M Saresella","year":"2011","unstructured":"Saresella, M. et al. Increased activity of Th-17 and Th-9 lymphocytes and a skewing of the post-thymic differentiation pathway are seen in Alzheimer\u2019s disease. Brain. Behav. Immun. 25, 539\u2013547 (2011).","journal-title":"Brain. Behav. Immun."},{"key":"575_CR142","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","volume":"9","author":"TJ Oberstein","year":"2018","unstructured":"Oberstein, T. J. et al. Imbalance of circulating Th17 and regulatory T cells in Alzheimer\u2019s disease: a case control study. Front. Immunol. 9, 1213 (2018).","journal-title":"Front. Immunol."},{"key":"575_CR143","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41574-019-0213-7","volume":"15","author":"WA Banks","year":"2019","unstructured":"Banks, W. A. The blood\u2013brain barrier as an endocrine tissue. Nat. Rev. Endocrinol. 15, 444\u2013455 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"575_CR144","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1161\/STROKEAHA.111.627562","volume":"43","author":"AMS Hartz","year":"2012","unstructured":"Hartz, A. M. S. et al. Amyloid-\u03b2 contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43, 514\u2013523 (2012).","journal-title":"Stroke"},{"key":"575_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075786","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang, J., Ke, K. F., Liu, Z., Qiu, Y. H. & Peng, Y. P. Th17 cell-mediated neuroinflammation is involved in neurodegeneration of A\u03b21-42-induced Alzheimer\u2019s disease model rats. PLoS ONE 8, e75786 (2013).","journal-title":"PLoS ONE"},{"key":"575_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-018-1380-5","volume":"16","author":"I St-Amour","year":"2019","unstructured":"St-Amour, I. et al. Peripheral adaptive immunity of the triple transgenic mouse model of Alzheimer\u2019s disease. J. Neuroinflammation 16, 3 (2019).","journal-title":"J. Neuroinflammation"},{"key":"575_CR147","doi-asserted-by":"publisher","first-page":"44\u201355.e6","DOI":"10.1016\/j.cmet.2020.04.015","volume":"32","author":"LP Bharath","year":"2020","unstructured":"Bharath, L. P. et al. Metformin enhances autophagy and normalizes mitochondrial function to alleviate aging-associated inflammation. Cell Metab. 32, 44\u201355.e6 (2020). In this study in humans, an oral metformin intervention improved T cell autophagy, indicating potential use for age-associated inflammation.","journal-title":"Cell Metab."},{"key":"575_CR148","doi-asserted-by":"publisher","first-page":"3544","DOI":"10.1111\/bph.14586","volume":"176","author":"C Cristiano","year":"2019","unstructured":"Cristiano, C. et al. Neutralization of IL-17 rescues amyloid-\u03b2-induced neuroinflammation and memory impairment. Br. J. Pharmacol. 176, 3544\u20133557 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"575_CR149","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s11481-020-09908-9","volume":"15","author":"JE Baulch","year":"2020","unstructured":"Baulch, J. E. et al. Immune and inflammatory determinants underlying Alzheimer\u2019s disease pathology. J. Neuroimmune Pharmacol. 15, 852\u2013862 (2020).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"575_CR150","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/JAD-150236","volume":"48","author":"S S\u00f6llvander","year":"2015","unstructured":"S\u00f6llvander, S. et al. Increased number of plasma B cells producing autoantibodies against A\u03b2 42 protofibrils in Alzheimer\u2019s disease. J. Alzheimers Dis. 48, 63\u201372 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"575_CR151","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22479-4","volume":"12","author":"K Kim","year":"2021","unstructured":"Kim, K. et al. Therapeutic B-cell depletion reverses progression of Alzheimer\u2019s disease. Nat. Commun. 12, 2185 (2021).","journal-title":"Nat. Commun."},{"key":"575_CR152","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/nyas.12825","volume":"1362","author":"NE Holodick","year":"2015","unstructured":"Holodick, N. E. & Rothstein, T. L. B cells in the aging immune system: time to consider B-1 cells. Ann. N. Y. Acad. Sci. 1362, 176\u2013187 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"575_CR153","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrendo.2015.7","volume":"11","author":"SSC Calvo","year":"2015","unstructured":"Calvo, S. S. C. & Egan, J. M. The endocrinology of taste receptors. Nat. Rev. Endocrinol. 11, 213\u2013227 (2015). This review provides an improved comprehension of the relationships between taste, palatability and taste receptors, which might lead to increased understanding of the development of obesity.","journal-title":"Nat. Rev. Endocrinol."},{"key":"575_CR154","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00415-009-5300-6","volume":"257","author":"S Steinbach","year":"2010","unstructured":"Steinbach, S. et al. Taste in mild cognitive impairment and Alzheimer\u2019s disease. J. Neurol. 257, 238\u2013246 (2010).","journal-title":"J. Neurol."},{"key":"575_CR155","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3233\/JAD-200376","volume":"76","author":"RM Wood","year":"2020","unstructured":"Wood, R. M. et al. Selective peripheral taste dysfunction in APP\/PS1 mutant transgenic mice. J. Alzheimers Dis. 76, 613\u2013621 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"575_CR156","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1083\/jcb.27.2.263","volume":"27","author":"LM Beidler","year":"1965","unstructured":"Beidler, L. M. & Smallman, R. L. Renewal of cells within taste buds. J. Cell Biol. 27, 263\u2013272 (1965).","journal-title":"J. Cell Biol."},{"key":"575_CR157","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4103\/ijem.IJEM_555_17","volume":"22","author":"S Khera","year":"2018","unstructured":"Khera, S. & Saigal, A. Assessment and evaluation of gustatory functions in patients with diabetes mellitus type II: a study. Indian J. Endocrinol. Metab. 22, 204\u2013207 (2018).","journal-title":"Indian J. Endocrinol. Metab."},{"key":"575_CR158","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.tripleo.2009.08.015","volume":"108","author":"SM Gondivkar","year":"2009","unstructured":"Gondivkar, S. M., Indurkar, A., Degwekar, S. & Bhowate, R. Evaluation of gustatory function in patients with diabetes mellitus type 2. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 108, 876\u2013880 (2009).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod."},{"key":"575_CR159","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/s41366-018-0303-y","volume":"43","author":"N Archer","year":"2019","unstructured":"Archer, N. et al. Obesity is associated with altered gene expression in human tastebuds. Int. J. Obes. 43, 1475\u20131484 (2019).","journal-title":"Int. J. Obes."},{"key":"575_CR160","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41366-019-0429-6","volume":"44","author":"A Kaufman","year":"2020","unstructured":"Kaufman, A., Kim, J., Noel, C. & Dando, R. Taste loss with obesity in mice and men. Int. J. Obes. 44, 739\u2013743 (2020).","journal-title":"Int. J. Obes."},{"key":"575_CR161","doi-asserted-by":"publisher","first-page":"7924052","DOI":"10.1155\/2016\/7924052","volume":"2016","author":"N Remla","year":"2016","unstructured":"Remla, N., Hadjidj, Z., Ghezzaz, K., Moulessehoul, S. & Aribi, M. Increased gustatory response score in obesity and association levels with IL-6 and leptin. J. Nutr. Metab. 2016, 7924052 (2016).","journal-title":"J. Nutr. Metab."},{"key":"575_CR162","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/oby.21871","volume":"25","author":"S Camandola","year":"2017","unstructured":"Camandola, S. & Mattson, M. P. Toll-like receptor 4 mediates fat, sugar, and umami taste preference and food intake and body weight regulation. Obesity 25, 1237\u20131245 (2017). In this paper, TLR4 signalling promoted ingestion of dietary sugar and fat by a mechanism involving increased preference for such obesogenic foods.","journal-title":"Obesity"},{"key":"575_CR163","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043140","volume":"7","author":"P Feng","year":"2012","unstructured":"Feng, P., Zhao, H., Chai, J., Huang, L. & Wang, H. Expression and secretion of TNF-\u03b1 in mouse taste buds: a novel function of a specific subset of type II taste cells. PLoS ONE 7, e43140 (2012).","journal-title":"PLoS ONE"},{"key":"575_CR164","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2001959","volume":"16","author":"A Kaufman","year":"2018","unstructured":"Kaufman, A., Choo, E., Koh, A. & Dando, R. Inflammation arising from obesity reduces taste bud abundance and inhibits renewal. PLoS Biol. 16, e2001959 (2018).","journal-title":"PLoS Biol."},{"key":"575_CR165","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbi.2015.04.001","volume":"49","author":"P Feng","year":"2015","unstructured":"Feng, P. et al. Regulation of bitter taste responses by tumor necrosis factor. Brain Behav. Immun. 49, 32\u201342 (2015).","journal-title":"Brain Behav. Immun."},{"key":"575_CR166","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbi.2009.02.016","volume":"23","author":"P Feng","year":"2009","unstructured":"Feng, P. et al. Immune cells of the human peripheral taste system: dominant dendritic cells and CD4 T cells. Brain. Behav. Immun. 23, 760\u2013766 (2009).","journal-title":"Brain. Behav. Immun."},{"key":"575_CR167","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/chemse\/bjq040","volume":"35","author":"H Pu Feng","year":"2010","unstructured":"Pu Feng, H., Wang, R. S., Feldman, E. A. & Pribitkin, A. S. B. The T cells in peripheral taste tissue of healthy human adults: predominant memory T cells and Th-1 cells. Chem. Senses 35, 501\u2013509 (2010).","journal-title":"Chem. Senses"},{"key":"575_CR168","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1523\/JNEUROSCI.3102-07.2007","volume":"27","author":"H Wang","year":"2007","unstructured":"Wang, H., Zhou, M., Brand, J. & Huang, L. Inflammation activates the interferon signaling pathways in taste bud cells. J. Neurosci. 27, 10703\u201310713 (2007).","journal-title":"J. Neurosci."},{"key":"575_CR169","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1523\/JNEUROSCI.3074-13.2014","volume":"34","author":"P Feng","year":"2014","unstructured":"Feng, P. et al. Interleukin-10 is produced by a specific subset of taste receptor cells and critical for maintaining structural integrity of mouse taste buds. J. Neurosci. 34, 2689\u20132701 (2014).","journal-title":"J. Neurosci."},{"key":"575_CR170","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/prd.12298","volume":"83","author":"D Polak","year":"2020","unstructured":"Polak, D., Sanui, T., Nishimura, F. & Shapira, L. Diabetes as a risk factor for periodontal disease \u2013 plausible mechanisms. Periodontology 83, 46\u201358 (2020).","journal-title":"Periodontology"},{"key":"575_CR171","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-030-28524-1_4","volume":"1197","author":"BS Nikolajczyk","year":"2019","unstructured":"Nikolajczyk, B. S. & Dawson, D. R. Origin of Th17 cells in type 2 diabetes-potentiated periodontal disease. Adv. Exp. Med. Biol. 1197, 45\u201354 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"575_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12505-x","volume":"10","author":"X Zheng","year":"2019","unstructured":"Zheng, X. et al. Gingival solitary chemosensory cells are immune sentinels for periodontitis. Nat. Commun. 10, 4496 (2019).","journal-title":"Nat. Commun."},{"key":"575_CR173","doi-asserted-by":"publisher","first-page":"eaat0797","DOI":"10.1126\/scitranslmed.aat0797","volume":"10","author":"N Dutzan","year":"2018","unstructured":"Dutzan, N. et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci. Transl. Med. 10, eaat0797 (2018).","journal-title":"Sci. Transl. Med."},{"key":"575_CR174","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76038-w","volume":"10","author":"C Alvarez","year":"2020","unstructured":"Alvarez, C. et al. Regulatory T cell phenotype and anti-osteoclastogenic function in experimental periodontitis. Sci. Rep. 10, 19018 (2020).","journal-title":"Sci. Rep."},{"key":"575_CR175","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-3-030-28524-1_9","volume":"1197","author":"N Dutzan","year":"2019","unstructured":"Dutzan, N. & Abusleme, L. T Helper 17 cells as pathogenic drivers of periodontitis. Adv. Exp. Med. Biol. 1197, 107\u2013117 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"575_CR176","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1189\/jlb.4A0214-095R","volume":"96","author":"M Zhu","year":"2014","unstructured":"Zhu, M. et al. B cells promote obesity-associated periodontitis and oral pathogen-associated inflammation. J. Leukoc. Biol. 96, 349\u2013357 (2014).","journal-title":"J. Leukoc. Biol."},{"key":"575_CR177","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1038\/nm.2505","volume":"17","author":"N Shulzhenko","year":"2011","unstructured":"Shulzhenko, N. et al. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17, 1585\u20131593 (2011).","journal-title":"Nat. Med."},{"key":"575_CR178","doi-asserted-by":"publisher","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","volume":"6","author":"V Braniste","year":"2014","unstructured":"Braniste, V. et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6, 263ra158 (2014).","journal-title":"Sci. Transl. Med."},{"key":"575_CR179","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/mi.2017.116","volume":"11","author":"R Lira-Junior","year":"2018","unstructured":"Lira-Junior, R. & Bostr\u00f6m, E. A. Oral-gut connection: one step closer to an integrated view of the gastrointestinal tract? Mucosal Immunol. 11, 316\u2013318 (2018).","journal-title":"Mucosal Immunol."},{"key":"575_CR180","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cmet.2020.02.008","volume":"31","author":"EM Teichman","year":"2020","unstructured":"Teichman, E. M., O\u2019Riordan, K. J., Gahan, C. G. M., Dinan, T. G. & Cryan, J. F. When rhythms meet the blues: circadian interactions with the microbiota-gut-brain axis. Cell Metab. 31, 448\u2013471 (2020).","journal-title":"Cell Metab."},{"key":"575_CR181","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.cmet.2017.05.008","volume":"26","author":"TS Postler","year":"2017","unstructured":"Postler, T. S. & Ghosh, S. Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 26, 110\u2013130 (2017).","journal-title":"Cell Metab."},{"key":"575_CR182","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913\u2013916.e7 (2012).","journal-title":"Gastroenterology"},{"key":"575_CR183","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cmet.2015.06.001","volume":"22","author":"L Garidou","year":"2015","unstructured":"Garidou, L. et al. The gut microbiota regulates intestinal CD4 T cells expressing ROR\u03b3t and controls metabolic disease. Cell Metab. 22, 100\u2013112 (2015). In this study, high-fat diet feeding induced gut microbiota dysbiosis which impaired the intestinal immune defence, including reduced intestinal IL-17-expressing T cells.","journal-title":"Cell Metab."},{"key":"575_CR184","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.immuni.2019.06.002","volume":"51","author":"A Bachem","year":"2019","unstructured":"Bachem, A. et al. Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity 51, 285\u2013297.e5 (2019).","journal-title":"Immunity"},{"key":"575_CR185","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1172\/JCI133264","volume":"130","author":"Y Xie","year":"2020","unstructured":"Xie, Y. et al. Gut epithelial TSC1\/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer. J. Clin. Invest. 130, 2111\u20132128 (2020).","journal-title":"J. Clin. Invest."},{"key":"575_CR186","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1152\/physiol.00041.2015","volume":"31","author":"MJA Saad","year":"2016","unstructured":"Saad, M. J. A., Santos, A. & Prada, P. O. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology 31, 283\u2013293 (2016).","journal-title":"Physiology"},{"key":"575_CR187","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2017.02.016","volume":"152","author":"CP Hong","year":"2017","unstructured":"Hong, C. P. et al. Gut-specific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice. Gastroenterology 152, 1998\u20132010 (2017).","journal-title":"Gastroenterology"},{"key":"575_CR188","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11370-y","volume":"10","author":"H Luck","year":"2019","unstructured":"Luck, H. et al. Gut-associated IgA+ immune cells regulate obesity-related insulin resistance. Nat. Commun. 10, 3650 (2019).","journal-title":"Nat. Commun."},{"key":"575_CR189","first-page":"635","volume":"137","author":"L He","year":"2009","unstructured":"He, L. et al. Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding. Protein Cell 137, 635\u2013646 (2009).","journal-title":"Protein Cell"},{"key":"575_CR190","doi-asserted-by":"publisher","first-page":"840","DOI":"10.5114\/aoms.2015.53304","volume":"11","author":"D Sola","year":"2015","unstructured":"Sola, D. et al. Sulfonylureas and their use in clinical practice. Arch. Med. Sci. 11, 840\u2013848 (2015).","journal-title":"Arch. Med. Sci."},{"key":"575_CR191","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3389\/fendo.2019.00376","volume":"10","author":"B Ahr\u00e9n","year":"2019","unstructured":"Ahr\u00e9n, B. DPP-4 inhibition and the path to clinical proof. Front. Endocrinol. 10, 376 (2019).","journal-title":"Front. Endocrinol."},{"key":"575_CR192","unstructured":"Food and Drug Administration. Highlights of prescribing information: BYETTA (exenatide) Injection. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2009\/021773s9s11s18s22s25lbl.pdf (2009)."},{"key":"575_CR193","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.imbio.2013.03.002","volume":"218","author":"M Sumarac-Dumanovic","year":"2013","unstructured":"Sumarac-Dumanovic, M. et al. Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels. Immunobiology 218, 1113\u20131118 (2013).","journal-title":"Immunobiology"},{"key":"575_CR194","doi-asserted-by":"publisher","first-page":"5813030","DOI":"10.1155\/2016\/5813030","volume":"2016","author":"EK Kim","year":"2016","unstructured":"Kim, E. K. et al. Metformin prevents fatty liver and improves balance of white\/brown adipose in an obesity mouse model by inducing FGF21. Med. Inflamm. 2016, 5813030 (2016).","journal-title":"Med. Inflamm."},{"key":"575_CR195","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13098-016-0169-x","volume":"8","author":"T Jojima","year":"2016","unstructured":"Jojima, T. et al. Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes. Diabetol. Metab. Syndr. 8, 45 (2016).","journal-title":"Diabetol. Metab. Syndr."},{"key":"575_CR196","first-page":"233","volume":"57","author":"LG Savchenko","year":"2019","unstructured":"Savchenko, L. G. et al. Liraglutide exerts an anti-inflammatory action in obese patients with type 2 diabetes. Rom. J. Intern. Med. 57, 233\u2013240 (2019).","journal-title":"Rom. J. Intern. Med."},{"key":"575_CR197","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/oby.22794","volume":"28","author":"RF Kushner","year":"2020","unstructured":"Kushner, R. F. et al. Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5. Obesity 28, 1050\u20131061 (2020).","journal-title":"Obesity"},{"key":"575_CR198","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03552757 (2021)."},{"key":"575_CR199","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/apt.15316","volume":"50","author":"P Newsome","year":"2019","unstructured":"Newsome, P. et al. Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and\/or obesity. Aliment. Pharmacol. Ther. 50, 193\u2013203 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"575_CR200","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","volume":"384","author":"PN Newsome","year":"2021","unstructured":"Newsome, P. N. et al. A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N. Engl. J. Med. 384, 1113\u20131124 (2021).","journal-title":"N. Engl. J. Med."},{"key":"575_CR201","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.2337\/diabetes.54.5.1566","volume":"54","author":"H S","year":"2005","unstructured":"S, H. et al. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 54, 1566\u20131572 (2005).","journal-title":"Diabetes"},{"key":"575_CR202","doi-asserted-by":"publisher","first-page":"R22","DOI":"10.1186\/ar2133","volume":"9","author":"J Boyer","year":"2007","unstructured":"Boyer, J. et al. Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes. Arthritis Res. Ther. 9, R22 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"575_CR203","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1474-4422(17)30007-8","volume":"16","author":"T Kalincik","year":"2017","unstructured":"Kalincik, T. et al. Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study. Lancet Neurol. 16, 271\u2013281 (2017).","journal-title":"Lancet Neurol."},{"key":"575_CR204","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clim.2017.07.005","volume":"183","author":"M Ogura","year":"2017","unstructured":"Ogura, M. et al. Oral treatment with foralumab, a fully human anti-CD3 monoclonal antibody, prevents skin xenograft rejection in humanized mice. Clin. Immunol. 183, 240\u2013246 (2017).","journal-title":"Clin. Immunol."},{"key":"575_CR205","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/show\/NCT03291249 (2019)."},{"key":"575_CR206","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/dc09-0533","volume":"32","author":"CM Larsen","year":"2009","unstructured":"Larsen, C. M. et al. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care 32, 1663\u20131668 (2009).","journal-title":"Diabetes Care"},{"key":"575_CR207","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1210\/jc.2010-2992","volume":"96","author":"EJP Van Asseldonk","year":"2011","unstructured":"Van Asseldonk, E. J. P. et al. Treatment with anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 96, 2119\u20132126 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"575_CR208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002901","volume":"16","author":"P Ruscitti","year":"2019","unstructured":"Ruscitti, P. et al. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial. PLoS Med. 16, e1002901 (2019).","journal-title":"PLoS Med."},{"key":"575_CR209","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.2337\/dc12-1835","volume":"36","author":"J Sloan-Lancaster","year":"2013","unstructured":"Sloan-Lancaster, J. et al. Double-blind, randomized study evaluating the glycemic and antiinflammatory effects of subcutaneous LY2189102, a neutralizing IL-1\u03b2 antibody, in patients with type 2 diabetes. Diabetes Care 36, 2239\u20132246 (2013).","journal-title":"Diabetes Care"},{"key":"575_CR210","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","volume":"71","author":"BM Everett","year":"2018","unstructured":"Everett, B. M. et al. Anti-inflammatory therapy with canakinumab for the prevention and management of diabetes. J. Am. Coll. Cardiol. 71, 2392\u20132401 (2018).","journal-title":"J. Am. Coll. Cardiol."},{"key":"575_CR211","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.jacc.2016.07.768","volume":"68","author":"RP Choudhury","year":"2016","unstructured":"Choudhury, R. P. et al. Arterial effects of canakinumab in patients with atherosclerosis and type 2 diabetes or glucose intolerance. J. Am. Coll. Cardiol. 68, 1769\u20131780 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"575_CR212","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.clinthera.2014.08.004","volume":"36","author":"A Noe","year":"2014","unstructured":"Noe, A., Howard, C., Thuren, T., Taylor, A. & Skerjanec, A. Pharmacokinetic and pharmacodynamic characteristics of single-dose canakinumab in patients with type 2 diabetes mellitus. Clin. Ther. 36, 1625\u20131637 (2014).","journal-title":"Clin. Ther."},{"key":"575_CR213","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/mt.2015.227","volume":"24","author":"C Cavelti-Weder","year":"2016","unstructured":"Cavelti-Weder, C. et al. Development of an interleukin-1\u03b2 vaccine in patients with type 2 diabetes. Mol. Ther. 24, 1003\u20131012 (2016).","journal-title":"Mol. Ther."},{"key":"575_CR214","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.2337\/dc17-0374","volume":"40","author":"CRL Cardoso","year":"2017","unstructured":"Cardoso, C. R. L. et al. Efficacy and safety of diacerein in patients with inadequately controlled type 2 diabetes: a randomized controlled trial. Diabetes Care 40, 1356\u20131363 (2017).","journal-title":"Diabetes Care"},{"key":"575_CR215","doi-asserted-by":"publisher","first-page":"4246521","DOI":"10.1155\/2018\/4246521","volume":"2018","author":"GS Tres","year":"2018","unstructured":"Tres, G. S. et al. Effect of diacerein on metabolic control and inflammatory markers in patients with type 2 diabetes using antidiabetic agents: a randomized controlled trial. J. Diabetes Res. 2018, 4246521 (2018).","journal-title":"J. Diabetes Res."},{"key":"575_CR216","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000088261","volume":"42","author":"H Dominguez","year":"2005","unstructured":"Dominguez, H. et al. Metabolic and vascular effects of tumor necrosis factor-\u03b1 blockade with etanercept in obese patients with type 2 diabetes. J. Vasc. Res. 42, 517\u2013525 (2005).","journal-title":"J. Vasc. Res."},{"key":"575_CR217","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1001\/archinte.166.8.902","volume":"166","author":"LE Bernstein","year":"2006","unstructured":"Bernstein, L. E., Berry, J., Kim, S., Canavan, B. & Grinspoon, S. K. Effects of etanercept in patients with the metabolic syndrome. Arch. Intern. Med. 166, 902\u2013908 (2006).","journal-title":"Arch. Intern. Med."},{"key":"575_CR218","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","volume":"52","author":"J Koska","year":"2009","unstructured":"Koska, J. et al. The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study. Diabetologia 52, 385\u2013393 (2009).","journal-title":"Diabetologia"},{"key":"575_CR219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","volume":"159","author":"AB Goldfine","year":"2013","unstructured":"Goldfine, A. B. et al. Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial. Ann. Intern. Med. 159, 1\u201312 (2013).","journal-title":"Ann. Intern. Med."},{"key":"575_CR220","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S2213-8587(15)00261-2","volume":"3","author":"D de Zeeuw","year":"2015","unstructured":"de Zeeuw, D. et al. The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial. Lancet Diabetes Endocrinol. 3, 687\u2013696 (2015).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"575_CR221","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02217475 (2019)."},{"key":"575_CR222","doi-asserted-by":"publisher","first-page":"1586422","DOI":"10.1080\/20002297.2019.1586422","volume":"11","author":"I Olsen","year":"2019","unstructured":"Olsen, I. & Yamazaki, K. Can oral bacteria affect the microbiome of the gut? J. Oral. Microbiol. 11, 1586422 (2019).","journal-title":"J. Oral. Microbiol."},{"key":"575_CR223","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","volume":"58","author":"C Jiang","year":"2017","unstructured":"Jiang, C., Li, G., Huang, P., Liu, Z. & Zhao, B. The gut microbiota and Alzheimer\u2019s disease. J. Alzheimers Dis. 58, 1\u201315 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"575_CR224","unstructured":"Centers for Disease Control and Prevention. Leading causes of death: data for the U.S. www.cdc.govhttps:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm (2021)."},{"key":"575_CR225","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1902\/jop.2012.110676","volume":"83","author":"PI Eke","year":"2012","unstructured":"Eke, P. I., Thornton-Evans, G., Dye, B. & Genco, R. Advances in surveillance of periodontitis: the Centers for Disease Control and Prevention Periodontal Disease Surveillance Project. J. Periodontol. 83, 1337\u20131342 (2012).","journal-title":"J. Periodontol."},{"key":"575_CR226","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1111\/dom.13252","volume":"20","author":"KM Pantalone","year":"2018","unstructured":"Pantalone, K. M., Patel, H., Yu, M. & Fern\u00e1ndez Land\u00f3, L. Dulaglutide 1.5\u2009mg as an add-on option for patients uncontrolled on insulin: subgroup analysis by age, duration of diabetes and baseline glycated haemoglobin concentration. Diabetes Obes. Metab. 20, 1461\u20131469 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"575_CR227","doi-asserted-by":"publisher","first-page":"eaao1815","DOI":"10.1126\/scisignal.aao1815","volume":"11","author":"RA Romanov","year":"2018","unstructured":"Romanov, R. A. et al. Chemical synapses without synaptic vesicles: purinergic neurotransmission through a CALHM1 channel-mitochondrial signaling complex. Sci. Signal. 11, eaao1815 (2018).","journal-title":"Sci. Signal."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00575-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00575-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00575-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T20:09:43Z","timestamp":1675800583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-021-00575-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":227,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["575"],"URL":"https:\/\/doi.org\/10.1038\/s41574-021-00575-1","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]},"assertion":[{"value":"17 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}